ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for EOLS

Stock NameEvolus Inc
TickerEOLS(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS30052C1071
LEI549300VYQRYBQOT8V419

Show aggregate EOLS holdings

News associated with EOLS

BTIG Research Reiterates Buy Rating for Evolus (NASDAQ:EOLS)
Evolus (NASDAQ:EOLS – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities research analysts at BTIG Research in a research note issued to investors on Monday,Benzinga reports. They currently have a $18.00 target price on the stock. BTIG Research’s price objective would indicate a potential upside of 143.57% from the company’s current price. […] - 2025-09-10 02:40:50
Evolus (NASDAQ:EOLS) Cut to “Sell” at Wall Street Zen
Wall Street Zen lowered shares of Evolus (NASDAQ:EOLS – Free Report) from a hold rating to a sell rating in a research note published on Saturday morning. A number of other brokerages have also recently issued reports on EOLS. HC Wainwright reduced their price objective on Evolus from $27.00 to $20.00 and set a “buy” […] - 2025-08-12 03:11:00
Evolus (NASDAQ:EOLS) Hits New 1-Year Low Following Analyst Downgrade
Shares of Evolus, Inc. (NASDAQ:EOLS – Get Free Report) hit a new 52-week low during mid-day trading on Thursday after BTIG Research lowered their price target on the stock from $21.00 to $18.00. BTIG Research currently has a buy rating on the stock. Evolus traded as low as $5.85 and last traded at $6.37, with […] - 2025-08-07 02:24:59
Y Intercept Hong Kong Ltd Invests $449,000 in Evolus, Inc. (NASDAQ:EOLS)
Y Intercept Hong Kong Ltd purchased a new position in Evolus, Inc. (NASDAQ:EOLS – Free Report) in the 1st quarter, HoldingsChannel reports. The institutional investor purchased 37,361 shares of the company’s stock, valued at approximately $449,000. Other large investors have also recently made changes to their positions in the company. KLP Kapitalforvaltning AS bought a […] - 2025-07-29 05:16:59
Evolus (NASDAQ:EOLS) Shares Down 5.5% on Insider Selling
Evolus, Inc. (NASDAQ:EOLS – Get Free Report) shares dropped 5.5% on Tuesday following insider selling activity. The company traded as low as $9.31 and last traded at $9.42. Approximately 110,433 shares traded hands during trading, a decline of 88% from the average daily volume of 938,410 shares. The stock had previously closed at $9.96. Specifically, […] - 2025-06-18 02:10:53
Evolus (NASDAQ:EOLS) Shares Gap Up After Insider Buying Activity
Evolus, Inc. (NASDAQ:EOLS – Get Free Report) shares gapped up before the market opened on Wednesday following insider buying activity. The stock had previously closed at $9.87, but opened at $10.17. Evolus shares last traded at $10.38, with a volume of 256,876 shares. Specifically, Director Albert G. White III bought 20,000 shares of the company’s […] - 2025-06-12 02:15:00
Man Group plc Purchases Shares of 10,931 Evolus, Inc. (NASDAQ:EOLS)
Man Group plc purchased a new stake in Evolus, Inc. (NASDAQ:EOLS – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 10,931 shares of the company’s stock, valued at approximately $121,000. A number of other hedge funds also recently bought and sold shares […] - 2025-05-29 05:40:57
Nuveen Asset Management LLC Has $8.50 Million Stock Position in Evolus, Inc. (NASDAQ:EOLS)
Nuveen Asset Management LLC lowered its stake in shares of Evolus, Inc. (NASDAQ:EOLS – Free Report) by 14.2% during the 4th quarter, Holdings Channel.com reports. The firm owned 769,576 shares of the company’s stock after selling 127,530 shares during the quarter. Nuveen Asset Management LLC’s holdings in Evolus were worth $8,496,000 as of its most […] - 2025-05-29 04:56:56
BNP Paribas Financial Markets Has $400,000 Position in Evolus, Inc. (NASDAQ:EOLS)
BNP Paribas Financial Markets cut its stake in shares of Evolus, Inc. (NASDAQ:EOLS – Free Report) by 42.3% during the 4th quarter, Holdings Channel reports. The fund owned 36,213 shares of the company’s stock after selling 26,535 shares during the period. BNP Paribas Financial Markets’ holdings in Evolus were worth $400,000 as of its most […] - 2025-05-26 04:24:47
Price T Rowe Associates Inc. MD Buys 6,332 Shares of Evolus, Inc. (NASDAQ:EOLS)
Price T Rowe Associates Inc. MD increased its stake in Evolus, Inc. (NASDAQ:EOLS – Free Report) by 13.7% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 52,593 shares of the company’s stock after acquiring an additional 6,332 shares during the period. Price T Rowe Associates Inc. MD’s holdings in Evolus were worth […] - 2025-05-13 04:32:48
Schonfeld Strategic Advisors LLC Increases Position in Evolus, Inc. (NASDAQ:EOLS)
Schonfeld Strategic Advisors LLC lifted its position in shares of Evolus, Inc. (NASDAQ:EOLS – Free Report) by 62.6% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 34,700 shares of the company’s stock after buying an additional 13,363 shares during the period. Schonfeld Strategic Advisors LLC’s holdings in […] - 2025-05-12 05:42:54
Evolus, Inc. (NASDAQ:EOLS) Shares Sold by Invesco Ltd.
Invesco Ltd. reduced its position in Evolus, Inc. (NASDAQ:EOLS – Free Report) by 81.9% in the 4th quarter, HoldingsChannel.com reports. The fund owned 18,326 shares of the company’s stock after selling 83,072 shares during the quarter. Invesco Ltd.’s holdings in Evolus were worth $202,000 at the end of the most recent quarter. Other institutional investors […] - 2025-05-05 04:26:46
Thursday's ETF Movers: IHE, IHF
In trading on Thursday, the iShares U.S. Pharmaceuticals ETF is outperforming other ETFs, up about 4.6% on the day. Components of that ETF showing particular strength include shares of Eli Lilly, up about 16.3% and shares of Evolus, up about 5.4% on the day. And underperformin - 2025-04-17 13:05:12
ExodusPoint Capital Management LP Purchases New Position in Evolus, Inc. (NASDAQ:EOLS)
ExodusPoint Capital Management LP acquired a new position in shares of Evolus, Inc. (NASDAQ:EOLS – Free Report) during the 4th quarter, Holdings Channel reports. The fund acquired 13,525 shares of the company’s stock, valued at approximately $149,000. A number of other hedge funds and other institutional investors have also added to or reduced their stakes […] - 2025-04-15 04:38:57
KLP Kapitalforvaltning AS Invests $106,000 in Evolus, Inc. (NASDAQ:EOLS)
KLP Kapitalforvaltning AS bought a new position in shares of Evolus, Inc. (NASDAQ:EOLS – Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 9,600 shares of the company’s stock, valued at approximately $106,000. Several other large investors have also recently added to or reduced their […] - 2025-04-11 05:14:55
Evolus, Inc. (NASDAQ:EOLS) Position Boosted by Intech Investment Management LLC
Intech Investment Management LLC raised its holdings in shares of Evolus, Inc. (NASDAQ:EOLS – Free Report) by 32.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,674 shares of the company’s stock after acquiring an additional 4,613 shares during the period. […] - 2025-03-27 06:29:02
HC Wainwright Reaffirms “Buy” Rating for Evolus (NASDAQ:EOLS)
Evolus (NASDAQ:EOLS – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at HC Wainwright in a research note issued to investors on Wednesday,Benzinga reports. They currently have a $27.00 price objective on the stock. HC Wainwright’s price target would suggest a potential upside of 100.00% from the stock’s current price. Several […] - 2025-03-07 04:50:44
China Universal Asset Management Co. Ltd. Acquires 1,291 Shares of Evolus, Inc. (NASDAQ:EOLS)
China Universal Asset Management Co. Ltd. grew its holdings in Evolus, Inc. (NASDAQ:EOLS – Free Report) by 10.6% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 13,426 shares of the company’s stock after acquiring an additional 1,291 shares during the period. China Universal Asset Management Co. Ltd.’s holdings in Evolus were worth $148,000 […] - 2025-02-04 06:53:02

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) EOLS holdings

DateNumber of EOLS Shares HeldBase Market Value of EOLS SharesLocal Market Value of EOLS SharesChange in EOLS Shares HeldChange in EOLS Base ValueCurrent Price per EOLS Share HeldPrevious Price per EOLS Share Held
2026-02-09 (Monday)45,353USD 192,297USD 192,297
2026-02-06 (Friday)45,253EOLS holding increased by 100USD 203,639EOLS holding decreased by -18062USD 203,639100USD -18,062 USD 4.50001 USD 4.91
2026-02-02 (Monday)45,153USD 221,701EOLS holding increased by 9933USD 221,7010USD 9,933 USD 4.91 USD 4.69001
2026-01-30 (Friday)45,153EOLS holding increased by 202USD 211,768EOLS holding increased by 2296USD 211,768202USD 2,296 USD 4.69001 USD 4.66001
2026-01-29 (Thursday)44,951EOLS holding increased by 101USD 209,472EOLS holding decreased by -12536USD 209,472101USD -12,536 USD 4.66001 USD 4.95001
2026-01-27 (Tuesday)44,850EOLS holding increased by 101USD 222,008EOLS holding increased by 6318USD 222,008101USD 6,318 USD 4.95001 USD 4.82
2026-01-26 (Monday)44,749USD 215,690EOLS holding decreased by -4475USD 215,6900USD -4,475 USD 4.82 USD 4.92
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of EOLS by Blackrock for IE00BYXG2H39

Show aggregate share trades of EOLS

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2026-02-06BUY100 4.500* -
2026-01-30BUY2024.7904.560 4.583USD 926 -
2026-01-29BUY1014.8254.620 4.640USD 469 -
2026-01-27BUY1014.9604.695 4.722USD 477 -
2026-01-23BUY2025.0804.880 4.900USD 990 -
2026-01-22BUY1015.1004.880 4.902USD 495 -
2026-01-15BUY2065.1304.740 4.779USD 984 -
2026-01-14BUY2065.7004.950 5.025USD 1,035 -
2026-01-12BUY2065.8855.490 5.529USD 1,139 -
2026-01-09BUY3095.8105.140 5.207USD 1,609 -
2026-01-07BUY2066.0405.615 5.657USD 1,165 -
2026-01-02BUY1036.7656.580 6.598USD 680 -
2025-12-30BUY1036.7406.565 6.583USD 678 -
2025-12-23SELL-1,2367.1606.790 6.827USD -8,438 -
2025-12-19SELL-6,6197.1707.005 7.022USD -46,475 -
2025-12-17SELL-6007.3307.050 7.078USD -4,247 -
2025-12-16SELL-1207.3107.100 7.121USD -855 -
2025-12-15BUY2407.2607.075 7.093USD 1,702 -
2025-12-11BUY2427.1506.845 6.875USD 1,664 -
2025-12-04BUY2,3606.8506.690 6.706USD 15,826 -
2025-12-02BUY1,7856.8206.355 6.402USD 11,427 -
2025-11-28BUY1197.1606.925 6.949USD 827 -
2025-11-26BUY3577.0606.930 6.943USD 2,479 -
2025-11-26BUY3577.0606.930 6.943USD 2,479 -
2025-11-25BUY5957.0356.800 6.824USD 4,060 -
2025-11-24BUY1196.8106.610 6.630USD 789 -
2025-11-20SELL-4727.0006.530 6.577USD -3,104 -
2025-11-19BUY1187.0306.690 6.724USD 793 -
2025-11-18BUY7087.1006.820 6.848USD 4,848 -
2025-11-17BUY2367.2706.930 6.964USD 1,644 -
2025-11-14BUY1187.5957.180 7.221USD 852 -
2025-11-12BUY1187.4256.950 6.997USD 826 -
2025-11-10BUY1177.2506.570 6.638USD 777 -
2025-11-06BUY1177.7607.105 7.171USD 839 -
2025-11-04BUY1186.6906.250 6.294USD 743 -
2025-10-30BUY5907.1406.665 6.712USD 3,960 -
2025-10-29BUY2366.8607.385 7.333USD 1,730 -
2025-10-22SELL-4686.8206.900 6.892USD -3,225 -
2025-10-20BUY2346.6906.710 6.708USD 1,570 -
2025-10-17BUY5846.4006.410 6.409USD 3,743 -
2025-10-15BUY9286.6106.620 6.619USD 6,142 -
2025-10-03BUY8336.5006.550 6.545USD 5,452 -
2025-10-02BUY1196.2406.350 6.339USD 754 -
2025-09-30BUY2386.1406.220 6.212USD 1,478 -
2025-09-26BUY2385.9906.040 6.035USD 1,436 -
2025-09-25BUY2385.9806.040 6.034USD 1,436 -
2025-09-24BUY16.0906.280 6.261USD 6 -
2025-09-18BUY1206.4206.590 6.573USD 789 -
2025-09-17BUY3606.5206.765 6.740USD 2,427 -
2025-08-20SELL-4687.2307.270 7.266USD -3,400 -
2025-07-30BUY4648.9609.360 9.320USD 4,324 -
2025-07-17SELL-2329.3409.425 9.417USD -2,185 -
2025-07-11SELL-9369.4809.750 9.723USD -9,101 -
2025-07-07BUY3519.1409.370 9.347USD 3,281 -
2025-07-02BUY6,4359.2109.390 9.372USD 60,309 -
2025-06-20BUY2,8619.2809.430 9.415USD 26,936 -
2025-06-11BUY21610.24010.620 10.582USD 2,286 -
2025-06-10BUY2169.8709.920 9.915USD 2,142 -
2025-06-04SELL-1089.80010.032 10.009USD -1,081 -
2025-04-23BUY10711.23011.360 11.347USD 1,214 -
2025-04-10SELL-8569.4159.910 9.860USD -8,441 -
2025-04-08SELL-1079.36010.710 10.575USD -1,132 -
2025-04-07SELL-10610.24010.744 10.694USD -1,134 -
2025-04-04SELL-53510.69010.910 10.888USD -5,825 -
2025-04-01BUY44011.99012.255 12.229USD 5,381 -
2025-03-31SELL-32112.03012.080 12.075USD -3,876 -
2025-03-21BUY1,82813.03013.300 13.273USD 24,263 -
2025-03-14SELL-1,63213.20013.215 13.214USD -21,564 -
2025-03-07SELL-20213.58013.810 13.787USD -2,785 -
2025-03-04SELL-10114.35014.430 14.422USD -1,457 -
2025-02-25BUY20413.96014.320 14.284USD 2,914 -
2025-02-19SELL-10114.88015.060 15.042USD -1,519 -
2025-02-13BUY30315.04017.120 16.912USD 5,124 -
2025-02-12BUY10114.26014.280 14.278USD 1,442 -
2025-02-11BUY40413.77013.830 13.824USD 5,585 -
2024-12-30SELL-3,09810.89011.060 11.043USD -34,211 -
2024-11-18SELL-1,63511.99012.670 12.602USD -20,604 -
2024-11-08SELL-10813.68014.350 14.283USD -1,543 -
2024-10-21SELL-10916.24016.690 16.645USD -1,814 -
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of EOLS

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19165,8570394,93542.0%
2025-09-18265,3880432,37561.4%
2025-09-17289,2120362,09579.9%
2025-09-16454,4600617,22773.6%
2025-09-15518,0540813,57463.7%
2025-09-1294,3970266,24835.5%
2025-09-11117,7300251,10746.9%
2025-09-10221,2490471,57846.9%
2025-09-09189,5090530,95535.7%
2025-09-08158,9069224,45370.8%
2025-09-0592,2630159,63557.8%
2025-09-04156,4850238,30865.7%
2025-09-03167,2700311,11153.8%
2025-09-0290,7620189,69747.8%
2025-08-2985,2310148,58157.4%
2025-08-28109,4090262,04341.8%
2025-08-27150,4910244,89761.5%
2025-08-26200,4530382,54552.4%
2025-08-25257,6090368,33869.9%
2025-08-22217,9520434,02650.2%
2025-08-21202,484200305,22966.3%
2025-08-20155,4800239,96664.8%
2025-08-19280,9040484,21858.0%
2025-08-18222,6730382,35258.2%
2025-08-15233,4450454,20251.4%
2025-08-14345,977900500,40769.1%
2025-08-13350,2843,451614,47057.0%
2025-08-12297,4230824,18536.1%
2025-08-11390,4821,2311,047,79737.3%
2025-08-08680,3114011,214,77856.0%
2025-08-07631,85537,2681,655,30738.2%
2025-08-062,974,051202,4456,786,16043.8%
2025-08-05475,6739,4001,756,06727.1%
2025-08-04234,530262665,73135.2%
2025-08-01284,8130802,15635.5%
2025-07-31130,0570533,43724.4%
2025-07-30115,3910699,37416.5%
2025-07-29201,5610403,72949.9%
2025-07-2884,2950221,07138.1%
2025-07-25184,9800557,60433.2%
2025-07-24250,6940807,60531.0%
2025-07-2387,7970338,47125.9%
2025-07-2274,974181283,38026.5%
2025-07-21112,7920285,06739.6%
2025-07-18190,8560391,15348.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy